Peptidomimetics: A New Frontier in Neurodegenerative Treatment
Neurotrophin Peptidomimetics
A New Hope for Neurodegenerative Disorders
Understanding Neurodegenerative Diseases
Neurodegenerative diseases (NDs) pose a significant global health challenge. Neurotrophins, essential proteins for neuronal survival, have shown potential as treatments, but their instability limits their use.
The Promise of Peptidomimetics
Peptidomimetic drugs mimic natural proteins and can be repurposed to treat NDs by promoting neuronal growth and survival. They offer improved stability and bioavailability compared to endogenous neurotrophins.
Research Insights
Led by Prof. Ashis K. Mukherjee at IASST, researchers are exploring peptidomimetics to overcome the limitations of natural peptides. Their studies focus on signaling pathways and pharmacological targets for effective therapeutic applications.
Future Directions
As research progresses, peptidomimetics may become a key strategy in managing neurodegenerative disorders, with potential applications in other diseases like cancer.
Learn More
Comments
Post a Comment